Bibliography

Filters: Keyword is Biomedical Technology  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z   [Show ALL]
A
Assasi N, Schwartz L, Tarride J-, Campbell K, Goeree R. Methodological guidance documents for evaluation of ethical considerations in health technology assessment: a systematic review. Expert Rev Pharmacoecon Outcomes Res. 2014;14(2):203-20. Abstract
C
Cavazza M, Jommi C. Stakeholders involvement by HTA Organisations: why is so different? Health Policy. 2012;105(2-3):236-45. Abstract
Access with Evidence Development. HTAi Interest Sub-Group on Conditional Coverage and Evidence Development for Promising Technologies; 2010. Abstract
Culyer AJ, Bombard Y. An equity framework for health technology assessments. Med Decis Making. 2012;32(3):428-41. Abstract
D
Droste S, Gerhardus A. [Ethical aspects of short health technology assessments--a systematic review]. Z Arztl Fortbild Qualitatssich. 2003;97(10):711-5. Abstract
Drummond M, Tarricone R, Torbica A. Assessing the added value of health technologies: reconciling different perspectives. Value Health. 2013;16(1 Suppl):S7-13. Abstract
E
Elston J, Stein K. A rapid needs assessment of the provision of Health Technology Assessment in the south-west peninsula. J Public Health (Oxf). 2007;29(2):157-64. Abstract
F
Frønsdal KB, Facey K, Klemp M, Norderhaug IN, Mørland B, Røttingen J-. Health technology assessment to optimize health technology utilization: using implementation initiatives and monitoring processes. Int J Technol Assess Health Care. 2010;26(3):309-16. Abstract
G
Gallego G, Harris A. Evaluation in a disconnected healthcare system: problems and suggested solutions from the Australian HTA review. Expert Rev Pharmacoecon Outcomes Res. 2010;10(6):615-7.
Gauvin F-, Abelson J, Giacomini M, Eyles J, Lavis JN. "It all depends": conceptualizing public involvement in the context of health technology assessment agencies. Soc Sci Med. 2010;70(10):1518-26. Abstract
Gerhardus A. [The role of HTA in German health care. Do we need impact objectives?]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2006;49(3):233-40. Abstract
H
Henshall C, Schuller T, Mardhani-Bayne L. Using health technology assessment to support optimal use of technologies in current practice: the challenge of "disinvestment". Int J Technol Assess Health Care. 2012;28(3):203-10. Abstract
K
Klemp M, Frønsdal KB, Facey K. What principles should govern the use of managed entry agreements? Int J Technol Assess Health Care. 2011;27(1):77-83. Abstract
Kohli HS. Health technology assessment in Scotland. Natl Med J India. 2003;16(5):275-6.
M
Menon D, Stafinski T. Role of patient and public participation in health technology assessment and coverage decisions. Expert Rev Pharmacoecon Outcomes Res. 2011;11(1):75-89. Abstract
Migliore A, Ratti M, Cerbo M, Jefferson T. Health Technology Assessment: managing the introduction and use of medical devices in clinical practice in Italy. Expert Rev Med Devices. 2009;6(3):251-7. Abstract
Mueller DB, Govender M, Basu D. Health technology assessment in South Africa--future promise. S Afr Med J. 2011;101(5):286-7.
O
O'Malley SP. Issues facing the Australian Health Technology Assessment Review of medical technology funding. Med J Aust. 2010;193(1):30-3. Abstract
P
Perleth M, Gerhardus A, Lühmann D, Rüther A. [The curriculum Health Technology Assessment (HTA)]. Z Arztl Fortbild Qualitatssich. 2006;100(4):297-302. Abstract
W
Wasem J. [Short report on the German Health Technology Assessment]. Z Arztl Fortbild Qualitatssich. 2005;99(3):237-8.
Wild C. [Development and institutionalization of Health Technology Assessment in Austria: the Ludwig Boltzmann Institute for Health Technology Assessment]. Z Evid Fortbild Qual Gesundhwes. 2009;103(6):341-4.
X
Xie F, Bowen JM, Sutherland SC, Burke N, Blackhouse G, Tarride J-, et al. Using health technology assessment to support evidence-based decision-making in Canada: an academic perspective. Expert Rev Pharmacoecon Outcomes Res. 2011;11(5):513-21. Abstract